282 related articles for article (PubMed ID: 8294059)
1. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
[TBL] [Abstract][Full Text] [Related]
2. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole resistance of Candida krusei.
Manso E; Montillo M; Discepoli G; Leoni P
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
[TBL] [Abstract][Full Text] [Related]
4. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
Małafiej E; Adamiec AC; Tworzyańska U
Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
[TBL] [Abstract][Full Text] [Related]
5. [Changes in epidemiology of opportunistic infections due to Candida].
Odds FC
Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300
[No Abstract] [Full Text] [Related]
6. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
7. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
8. Candidemia and the susceptibility pattern of Candida isolates in blood.
Osoba AO; Al-Mowallad AW; McAlear DE; Hussein BA
Saudi Med J; 2003 Oct; 24(10):1060-3. PubMed ID: 14578968
[TBL] [Abstract][Full Text] [Related]
9. Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
Giusiano G; Mangiaterra M; Saito VG; Rojas F; Gómez V; Díaz MC
Mycoses; 2006 Jan; 49(1):49-54. PubMed ID: 16367819
[TBL] [Abstract][Full Text] [Related]
10. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
Samonis G; Kofteridis DP; Saloustros E; Giannopoulou KP; Ntziora F; Christidou A; Maraki S; Falagas ME
Scand J Infect Dis; 2008; 40(5):414-9. PubMed ID: 18418802
[TBL] [Abstract][Full Text] [Related]
11. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
Rimek D; Redetzke K; Kappe R
Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
[TBL] [Abstract][Full Text] [Related]
12. Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Krcméry V; Spánik S; Grausová S; Trupl J; Krupová I; Roidová A; Sálek T; Sufliarsky J; Mardiak J
Neoplasma; 1998; 45(5):336-42. PubMed ID: 9921924
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
[TBL] [Abstract][Full Text] [Related]
14. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
Marr KA; Seidel K; White TC; Bowden RA
J Infect Dis; 2000 Jan; 181(1):309-16. PubMed ID: 10608780
[TBL] [Abstract][Full Text] [Related]
15. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Minari A; Hachem R; Raad I
Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
[TBL] [Abstract][Full Text] [Related]
16. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
[No Abstract] [Full Text] [Related]
18. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
19. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
[TBL] [Abstract][Full Text] [Related]
20. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.
Alangaden G; Chandrasekar PH; Bailey E; Khaliq Y
Bone Marrow Transplant; 1994 Dec; 14(6):919-24. PubMed ID: 7711669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]